skip to navigation skip to content
Search

Myriam Ouberai

Yahoo Finance: Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

Spirea, a startup supported by the Accelerate Cambridge programme run by Cambridge Judge Business School’s Entrepreneurship Centre, has secured funding of £2.4 million with investments from high-profile UK and US investors. Dr Myriam Ouberai, Chief Executive Officer at Spirea, commented:…

Read more

Peptide therapeutics progress

Journal article on peptides co-authored by the co-founder of Accelerate Cambridge healthcare venture wins MedImmune 2017 Global Excellence Award for best publication. A journal article on peptides co-authored by the co-founder of a healthcare technology venture mentored on the Accelerate…

Read more

2018 News: Peptide therapeutics progress.

Archives